Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Concert VR Radiopaque Bone Cement is a polymethylmethacrylate (PMMA)-based acrylic bone cement developed by Advanced Biomaterial Systems, Inc. It is specifically designed and FDA-approved for use in kyphoplasty procedures to treat vertebral compression fractures. The product is a two-component system consisting of a powder (pre-polymerized PMMA) and a liquid (methyl methacrylate monomer) that, when mixed, undergo an exothermic polymerization reaction to form a hard, stone-like material. It includes radiopacifier agents to ensure high visibility under X-ray imaging during the injection process, allowing for precise placement within the vertebral body to provide structural stabilization and support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Concert VR Radiopaque Bone Cement.